Conversion to rapamycin immunosuppression in renal transplant recipients: Report of an initial experience

Transplantation

Volumn 70, Issue 8, 2000, Pages 1244-1247

  Dominguez, Javier ^a   Mahalati, Kamran ^a   Kiberd, Bryce ^a   McAlister, Vivian C ^a   MacDonald, Allan S ^a,b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; TACROLIMUS;

ADULT; APHTHOUS ULCER; ARTICLE; CLINICAL ARTICLE; DRUG BLOOD LEVEL; DRUG MONITORING; DRUG WITHDRAWAL; FACE DYSMORPHIA; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LIVER TOXICITY; LYMPHOPROLIFERATIVE DISEASE; MALE; NEPHROTOXICITY; OPPORTUNISTIC INFECTION; PNEUMONIA; PRIORITY JOURNAL; THROMBOCYTOPENIA;

EID: 0034721757     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200010270-00021     Document Type: Article

References (16)

1. Sirolimus (Rapamycin)-based therapy in human renal transplantation. Similar efficacy and different toxicity compared with cyclosporine
2. Rapamune (sirolimus, rapamycin). An overview and mechanism of action
3. Pivotal phase III multicenter, randomized, blinded trial of Sirolimus versus Azathioprine in combination with Cyclosporine and Prednisone in primary renal transplantation
4. A randomized trial of sirolimus, cyclosporine and prednisone vs. cyclosporine-prednisone alone in recipients of mismatched first kidney grafts: Results at one year
5. Risk factors for cyclosporine induced nephropathy in patients with autoimmune diseases. International kidney biopsy registry of cyclosporine in autoimmune diseases
6. Histopathologic findings from 2-year protocol biopsies from a U.S. multicenter kidney transplant trial comparing tacrolimus versus cyclosporine: A report of the FK-505 Kidney Transplant Study Group
7. Rapamycin inhibits arterial intimal thickening produced by both alloimmune and mechanical injury
8. Effects of Rapamycin on growth factor stimulated vascular smooth muscle cell DNA synthesis
9. Effect of the maintenance immunosuppressive drug regimen on kidney transplant outcome
10. Elective cyclosporine withdrawal after renal transplantation. A meta-analysis
11. A blinded, long-term, randomized multicenter study of mycophenolate mofetil in cadaveric renal transplantation: Results at three years. Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group
12. Mycophenolate mofetil-based, cyclosporine free induction and maintenance immunosuppression
13. A novel approach to the treatment of chronic allograft nephropathy
14. Sirolimus: A new agent for clinical renal transplantation
15. Bronchiolitis obliterans and organizing pneumonia in renal transplant recipients